Guess?, Inc. (GES) Misses Q3 EPS by 2c; Guides Q4, FY11 Below Views
Tweet
Share
E-mailGet Alerts GES Hot Sheet
Price: $16.81 --0%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.23
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Dividends declared per common share (in dollars per share): 0.23
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Guess?, Inc. (NYSE: GES) reported Q3 EPS of $0.71, $0.02 worse than the analyst estimate of $0.73. Revenue for the quarter came in at $642.8 million versus the consensus estimate of $654.98 million.
Guess?, Inc. sees Q4 2011 EPS of $1.03-$1.09, versus the consensus of $1.21. Guess?, Inc. sees Q4 2011 revenue of $780-$795 million, versus the consensus of $816 million.
Guess?, Inc. sees FY2011 EPS of $3.04-$3.10, versus the consensus of $3.27. Guess?, Inc. sees FY2011 revenue of $2.70-$2.71 billion, versus the consensus of $2.74 billion.
Guess?, Inc. sees Q4 2011 EPS of $1.03-$1.09, versus the consensus of $1.21. Guess?, Inc. sees Q4 2011 revenue of $780-$795 million, versus the consensus of $816 million.
Guess?, Inc. sees FY2011 EPS of $3.04-$3.10, versus the consensus of $3.27. Guess?, Inc. sees FY2011 revenue of $2.70-$2.71 billion, versus the consensus of $2.74 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
